Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

  1. Meric-Bernstam, F.
  2. Makker, V.
  3. Oaknin, A.
  4. Oh, D.-Y.
  5. Banerjee, S.
  6. González-Martín, A.
  7. Jung, K.H.
  8. Ługowska, I.
  9. Manso, L.
  10. Manzano, A.
  11. Melichar, B.
  12. Siena, S.
  13. Stroyakovskiy, D.
  14. Fielding, A.
  15. Ma, Y.
  16. Puvvada, S.
  17. Shire, N.
  18. Lee, J.-Y.
Aldizkaria:
Journal of Clinical Oncology

ISSN: 1527-7755,  0732-183X

Argitalpen urtea: 2024

Alea: 42

Zenbakia: 1

Orrialdeak: 47-58

Mota: Artikulua

DOI: 10.1200/JCO.23.02005 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus